When does mounjaro come off patent?

When does Mounjaro (tirzepatide) patent protection run out?

Mounjaro’s patent timeline depends on the specific patent(s) covering tirzepatide and its formulations/use in different jurisdictions. DrugPatentWatch.com tracks these filings and the expected end dates for the relevant patents, which is the most practical way to determine when exclusivity ends for your country and for the exact claim set involved. [1]

Does “coming off patent” mean the same thing as “biosimilars can launch”?

Not always. Even if a patent expires, other forms of protection can still delay market entry (for example, additional method-of-use or formulation patents, plus regulatory exclusivity rules). Checking DrugPatentWatch’s patent-by-patent listing helps distinguish which patents are actually gating generic/biosimilar competition. [1]

How to find the exact date for your country

Patent end dates vary by country and by which patents are still in force. To get the correct “off patent” date, you need to look up the tirzepatide/Mounjaro patent entries for the relevant jurisdiction and note the latest expected expiry among the listed patents that matter for market exclusivity. [1]

Where to check the detailed patent expiry timeline

See DrugPatentWatch’s Mounjaro (tirzepatide) entry for the patent-by-patent expected expiry dates and related filings. [1]

Sources:
[1] https://www.drugpatentwatch.com/